Resveratrol: Labeling Standards and Cross-Border Compliance

Abstract

Resveratrol (chemical name: 3,5,4'-trihydroxystilbene) is a polyphenolic compound found naturally in knotweed, grape skins, peanuts, and a range of other plants. It has seen sustained growth in the global dietary supplement market in recent years. Because regulatory classification, labeling requirements, and import/export rules differ significantly from one jurisdiction to the next, consumers face considerable compliance risk when purchasing across borders. This paper examines the current regulatory frameworks in Japan, Mainland China, the European Union, and the United States across three dimensions: ingredient content labeling standards, label compliance requirements, and cross-border purchasing compliance considerations. The aim is to provide consumers and industry practitioners with actionable reference guidance. No efficacy or medical claims are made herein; all discussion is strictly limited to verifiable aspects of labeling, testing, and information transparency.

---

1. Raw Material Sources and Specification Categories

1.1 Primary Plant Sources and Extract Specifications

Commercial resveratrol supplements are derived primarily from two plant sources: knotweed root (*Polygonum cuspidatum*, also marketed as knotweed extract) and grape skin or grape seed extracts. The former is the dominant raw material in the global health food industry due to its higher resveratrol concentration and more efficient extractability.

In terms of specification labeling, resveratrol raw materials are typically declared as either "Total Resveratrol" or "trans-Resveratrol." These are distinct designations:

• trans-Resveratrol: One of the two stereoisomers of resveratrol. It is the more stable form found in nature and the form most commonly quantified and labeled separately on the market.
• cis-Resveratrol: The less stable stereoisomer, with comparatively lower activity, which can be produced from the trans form under exposure to light or heat.
• Total Resveratrol: Generally refers to the combined quantity of both trans and cis isomers. Some manufacturers also include resveratrol glycosides (piceid/polydatin) in their total resveratrol figure — a practice that remains scientifically contested. Consumers should take care to distinguish between these reporting conventions.

1.2 Concentration Tiers and Common Commercial Specifications

The majority of products sold globally fall within the following daily serving ranges:

An important distinction: a label stating "X mg knotweed extract" and one stating "X mg trans-Resveratrol" convey entirely different information. The former refers to the input quantity of the raw botanical material; the latter specifies the actual content of the target active compound. The two figures are not interchangeable and must not be treated as equivalent.

---

2. Japan: Labeling Regulatory Framework

2.1 Food Labeling Act and the Functional Claims Food System

Japan's regulatory framework for dietary supplements centers on the Food Labeling Act (*Shokuhin Hyōji Hō*, in force since 2015), administered by the Consumer Affairs Agency (CAA), which also oversees the individual notification system for Functional Claims Foods (*Kinōsei Hyōji Shokuhin*).

Resveratrol has not been approved as an active ingredient under Japan's Foods for Specified Health Uses (FOSHU) program, nor has any Functional Claims Food notification for resveratrol been accepted by the CAA as of this document's information cutoff date. As a result, resveratrol-containing products on the market may not carry any label statements implying improvement of bodily functions. Such products may only be distributed as ordinary foods or as so-called health foods (*iwayuru kenkō shokuhin*) outside the recognized category framework.

2.2 Mandatory Ingredient Content Labeling Requirements

Under Article 3 of the Food Labeling Standards (*Shokuhin Hyōji Kijun*), the following requirements apply to the labeling of nutrients or specific ingredients:

• Content declarations must be expressed on a per-daily-serving basis (*1-nichi sesshu meayasu-ryō*). It is not permissible to state only the per-capsule amount while omitting the daily serving equivalent.
• Where a label states "formulated with ○○ mg" (*haigō*), that figure must correspond to a measurable, actual input quantity of the specified ingredient. The total weight of a mixture must not be substituted for the content of the target active compound.
• Where no content claim is made (i.e., the label does not voluntarily declare a quantity), no comparative statements implying a dosage advantage may appear anywhere on the label.

2.3 GMP and Third-Party Certification

The Japan Health and Nutrition Food Association (JHNFA) operates a GMP Conformity Certification (*GMP Tekigō Nintei*) scheme, under which manufacturing facilities are subject to periodic audits. Certification records are publicly accessible on the JHNFA website and can be verified by consumers using the registered facility number. Certified facilities must maintain full-chain quality management covering incoming raw material inspection, in-process controls, and finished-product release testing. This certification currently represents one of the most verifiable third-party manufacturing compliance signals available in the health food sector.

---

3. Mainland China: Labeling Regulatory Framework

3.1 Dual-Track Registration and Filing System for Health Foods

In Mainland China, products containing resveratrol are subject to classification-based administration under the Measures for the Registration and Filing of Health Foods (SAMR Order No. 22):

• Registration pathway: First-time imported health foods, or products making specific health function claims, must submit a registration application to the State Administration for Market Regulation (SAMR) and obtain an approval certificate (bearing the prefix "G" for domestic or "J" for imported products) before being placed on the market.
• Filing pathway: Domestically produced health foods formulated within the scope of the officially published Health Food Raw Material Catalogue may follow the more streamlined filing procedure, though regulatory standards are equivalent to those under the registration pathway.

Resveratrol is not currently listed in the Health Food Raw Material Catalogue published by SAMR. This means that domestically produced health foods containing this ingredient must proceed via the registration pathway, which carries more extensive documentation requirements and longer review timelines.

3.2 Mandatory Label Information and Key Compliance Points

Under the Guidelines on Warning Statements for Health Food Labels (effective 2020) and the National Food Safety Standard — General Rules for the Labeling of Prepackaged Foods (GB 7718), health food labels containing resveratrol must include:

• 1. Product name (no wording that implies therapeutic effects)
• 2. Declared health function(s) (limited strictly to approved claims, and must align with the registered health function designation)
• 3. Daily serving size and directions for use
• 4. Primary ingredients and excipients (the source of resveratrol must be specified; where "knotweed extract" is used, the plant part extracted and extract specification must be stated)
• 5. Content of functional or marker ingredients (expressed in mg per capsule or mg per day, and consistent with the registered approval documentation)
• 6. Warning statement: The phrase "This product cannot substitute for medicine" must appear in bold typeface, occupying no less than one-sixth of the total label surface area

Regarding ordinary foods (non-health foods): the addition of resveratrol to ordinary food products has no established regulatory authorization in Mainland China. Consumers purchasing products sold as ordinary foods on e-commerce platforms but marketed as "resveratrol supplements" should exercise particular caution, as such products may occupy a regulatory gray area.

---

4. European Union and United States: Labeling Framework Overview

4.1 European Union: Novel Food Regulation

The EU regulates resveratrol under the Novel Food Regulation (EU 2015/2283), which classifies as "novel food" any ingredient without a documented history of significant consumption within the EU prior to May 2000. Resveratrol extracts derived from knotweed held pending status on the EU authorized novel food list prior to 2023. In its assessment opinions, the European Food Safety Authority (EFSA) noted certain aspects warranting further evaluation in the context of high supplemental intake — though this reflects a procedural evaluation consideration and does not constitute a negative safety determination regarding the substance.

For products that have received authorization, EU labels must comply with the Food Information Regulation (EU 1169/2011), requiring declaration of daily intake amounts, ingredient origin, allergen information, and related particulars. Health claims not authorized by EFSA are prohibited from appearing on labels or in advertising.

4.2 United States: Dietary Supplement Framework

The United States classifies resveratrol as a dietary supplement, governed by the Dietary Supplement Health and Education Act (DSHEA, 1994), with the FDA exercising post-market rather than pre-market regulatory authority. Core label compliance requirements in the US include:

• A Supplement Facts panel must appear on the label, listing the amount per serving and the percent Daily Value where applicable.
• Structure/Function Claims must be notified to the FDA at least 30 days in advance and must be accompanied on the label by the standard disclaimer: *"This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."*
• Manufacturing facilities must comply with GMP standards under 21 CFR Part 111. However, the FDA does not mandate independent third-party testing; accordingly, consumers are advised to prioritize products bearing third-party certifications such as NSF, USP, or Informed Sport, which provide independent verification of labeled content.

---

5. Cross-Border Purchasing: Key Compliance Considerations

5.1 Personal Import and Mail-Order Restrictions

When purchasing dietary supplements across borders, customs clearance rules in the destination country are typically the most immediate compliance threshold:

Importing into Mainland China:

• Personal quantities of health food products for individual use are generally permitted through customs clearance, provided the quantity falls within a reasonable personal-use range (commonly referenced as no more than a three-month supply).
• Purchases made through cross-border e-commerce platforms (bonded warehouse model) must be declared within the Cross-Border E-Commerce Composite Tax framework, subject to an annual personal purchase limit of RMB 26,000 and a single-transaction limit of RMB 5,000.
• Note: Products sold commercially as health foods within Mainland China must hold the corresponding regulatory approval. A fundamental distinction exists at the regulatory level between personal-use importation and commercial distribution.

Importing into Japan:

• customs generally permit individuals to carry foreign health food products for personal use when entering the country. However, products classified as "pharmaceutical products" (*iyakuhin*) — including, in some cases, products with ingredient concentrations exceeding food-grade thresholds — are subject to different rules.
• For products entering by international mail, the Ministry of Health, Labour and Welfare's (MHLW) classification of certain constituents as "pharmaceutical ingredients" may result in customs delays or a requirement to submit ingredient documentation.

5.2 Label Language and Claim Equivalency Verification

Cross-border purchases expose consumers to information asymmetry arising from label language barriers:

• Discrepancies between inserts and original packaging: In some cases, -language inserts provided by distributors describe ingredient content differently from the original label — including instances where "total resveratrol" has been misrepresented as "trans-resveratrol." Consumers should treat the original packaging as authoritative and verify that both figures are consistent.
• "Export-only packaging" risk: Some products carry only the destination-market language on the label and lack complete compliance labeling from the country of manufacture. Consumers should verify that the product is also in regular commercial circulation in its home market.
• Third-party Certificate of Analysis (CoA) verification: Reputable manufacturers typically publish batch-specific third-party CoAs. Consumers may request the relevant batch CoA from the seller, or access it via the brand's official website, to verify that the actual trans-resveratrol content is consistent with the labeled value.

5.3 Compliance Risks in E-Commerce and Informal Resale Channels

Products purchased through social media resellers or unregulated e-commerce channels present the following verifiable compliance risks:

• 1. Inability to verify batch and manufacturing date: Informal resale channels typically cannot provide complete supply chain traceability. Storage and handling conditions are uncontrolled, and resveratrol is sensitive to both light and heat — improper handling can cause the trans isomer to convert to the cis form, reducing actual content below labeled levels.
• 2. Counterfeiting: Counterfeit products from well-known brands are a recognized problem in cross-border channels. Consumers can verify authenticity by scanning product anti-counterfeiting codes or checking batch information through the brand's official website.
• 3. Inaccurate content labeling: Some non-compliant products misrepresent resveratrol content by listing total plant extract weight in place of active compound content. Independent market testing published by organizations such as Labdoor and ConsumerLab can serve as reference resources for assessing labeled-versus-actual content accuracy.

---

6. Actionable Guidance for Consumers

The following steps represent practical verification actions consumers can take when selecting resveratrol supplements. All are grounded in labeling and traceability considerations and involve no efficacy judgments of any kind:

• 1. Distinguish "trans-Resveratrol" from "Total Resveratrol": Prioritize products whose labels explicitly state the "trans-Resveratrol" content, rather than products that only declare total plant extract weight or an undifferentiated "total resveratrol" figure.
• 2. Verify the basis of the daily serving declaration: Confirm that content is declared per daily serving (rather than per capsule only), and check that the arithmetic is internally consistent — i.e., number of capsules × per-capsule content = stated daily amount.
• 3. Check for third-party certification or batch CoA documentation: GMP certification (e.g., JHNFA GMP Conformity Certification in Japan; NSF GMP in the United States) and batch-specific CoA reports are the principal publicly verifiable credentials for manufacturing compliance. Consumers may request these from sellers or consult the brand's official website.
• 4. Confirm the product's compliant status in its country of manufacture: Verify that the product is in regular commercial distribution in its domestic market, and is not a product manufactured exclusively for export with unclear regulatory standing. Publicly accessible resources such as the National Institute of Health and Nutrition (Japan) Health Food Ingredient Information Database and the US FDA Dietary Supplement Databases can assist with this assessment.
• 5. Review storage condition labeling: Resveratrol is sensitive to light and elevated temperatures. Product labels should specify storage away from light and heat. If this information is absent from the label or the seller is unable to confirm shipping and storage conditions, this should be treated as a signal of insufficient information transparency.
• 6. Retain purchase records and customs documentation: When purchasing cross-border, retain complete purchase records, shipping documentation, and customs clearance paperwork. These records provide an evidentiary basis in the event of product issues and facilitate batch-source tracing through the platform or brand.

---

Conclusion

The global compliance landscape for resveratrol supplements is characterized by a fragmented, multi-regulator environment with divergent standards across jurisdictions. Japan centers its framework on the Food Labeling Act and the JHNFA GMP certification system, emphasizing precise labeling and verifiable manufacturing quality. Mainland China governs health function claims and ingredient sourcing through its dual-track registration and filing system. The European Union continues to evaluate resveratrol's market authorization conditions under the Novel Food framework. The United States relies on post-market regulatory oversight supplemented by third-party certification to address the absence of pre-market review.

For consumers, the core challenge of cross-border compliance is not determining which market offers superior products, but rather whether sufficient, verifiable labeling information is available — including ingredient source, actual content, batch traceability, and manufacturing compliance credentials. Where this information is complete and transparent, consumers are well positioned to make informed decisions in accordance with the import regulations of their jurisdiction. Any marketing claims that go beyond the scope of labeling transparency — such as guarantees of efficacy or assertions of disease improvement — should be treated as departures from regulatory requirements, regardless of the market in which they originate.

---

*Information current as of June 2026. The regulatory frameworks discussed are subject to ongoing revision. Readers should consult the latest published versions of the relevant regulatory instruments from the competent authorities before making specific purchasing or compliance decisions. Nothing in this document constitutes legal, medical, or investment advice.*